|
1
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: OncomiRs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huynh C, Segura MF, Gaziel-Sovran A,
Menendez S, Darvishian F, Chiriboga L, Levin B, Meruelo D, Osman I,
Zavadil J, et al: Efficient in vivo microRNA targeting of liver
metastasis. Oncogene. 30:1481–1488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun V, Zhou WB, Majid S, Kashani-Sabet M
and Dar AA: MicroRNA-mediated regulation of melanoma. Br J
Dermatol. 171:234–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu J, Dou Y and Sheng M: Inhibition of
microRNA-383 has tumor suppressive effect in human epithelial
ovarian cancer through the action on caspase-2 gene. Biomed
Pharmacother. 83:1286–1294. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang X, Zhu W, Zhang H and Lian S:
Sensitization of melanoma cells to temozolomide by overexpression
of microRNA 203 through direct targeting of glutaminase-mediated
glutamine metabolism. Clin Exp Dermatol. 42:614–621. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simpson RM, Bastian BC, Michael HT,
Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt
MH, Esplin DG, Smedley RC, et al: Sporadic naturally occurring
melanoma in dogs as a preclinical model for human melanoma. Pigment
Cell Melanoma Res. 27:37–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uhl E, Krimer P, Schliekelman P, Tompkins
SM and Suter S: Identification of altered MicroRNA expression in
canine lymphoid cell lines and cases of B- and T-cell lymphomas.
Genes Chromosomes Cancer. 50:950–967. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gioia G, Mortarino M, Gelain ME, Albonico
F, Ciusani E, Forno I, Marconato L, Martini V and Comazzi S:
Immunophenotype-related microRNA expression in canine chronic
lymphocytic leukemia. Vet Immunol Immunopathol. 142:228–235. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vinall RL, Kent MS and deVere White RW:
Expression of microRNAs in urinary bladder samples obtained from
dogs with grossly normal bladders, inflammatory bladder disease, or
transitional cell carcinoma. Am J Vet Res. 73:1626–1633. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boggs RM, Wright ZM, Stickney MJ, Porter
WW and Murphy KE: MicroRNA expression in canine mammary cancer.
Mamm Genome. 19:561–569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kobayashi M, Saito A, Tanaka Y, Michishita
M, Kobayashi M, Irimajiri M, Kaneda T, Ochiai K, Bonkobara M,
Takahashi K, et al: MicroRNA expression profiling in canine
prostate cancer. J Vet Med Sci. 79:719–725. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noguchi S, Mori T, Hoshino Y, Yamada N,
Nakagawa T, Sasaki N, Akao Y and Maruo K: Comparative study of
anti-oncogenic microRNA-145 in canine and human malignant melanoma.
J Vet Med Sci. 74:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noguchi S, Mori T, Hoshino Y, Yamada N,
Maruo K and Akao Y: MicroRNAs as tumour suppressors in canine and
human melanoma cells and as a prognostic factor in canine
melanomas. Vet Comp Oncol. 11:113–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Starkey MP, Compston-Garnett L, Malho P,
Dunn K and Dubielzig R: Metastasis-associated microRNA expression
in canine uveal melanoma. Vet Comp Oncol. 16:81–89. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Bian Z, Wei D and Zhang JG:
miR-29b regulates migration of human breast cancer cells. Mol Cell
Biochem. 352:197–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Latchana N, Ganju A, Howard JH and Carson
WE III: MicroRNA dysregulation in melanoma. Surg Oncol. 25:184–189.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmitt MJ, Philippidou D, Reinsbach SE,
Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I and Kreis S:
Interferon-γ-induced activation of signal transducer and activator
of transcription 1 (STAT1) up-regulates the tumor suppressing
microRNA-29 family in melanoma cells. Cell Commun Signal.
10:412012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hartwell LH, Hopfield JJ, Leibler S and
Murray AW: From molecular to modular cell biology. Nature.
402:(6761 Suppl)C47–C52. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu W, Yang L and Du Z: MicroRNA
regulation and tissue-specific protein interaction network. PLoS
One. 6:e253942011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schroeder A, Mueller O, Stocker S,
Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M
and Ragg T: The RIN: An RNA integrity number for assigning
integrity values to RNA measurements. BMC Mol Biol. 7:32006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao Y, Wang E, Liu H, Rotunno M, Koshiol
J, Marincola FM, Landi MT and McShane LM: Evaluation of
normalization methods for two-channel microRNA microarrays. J
Transl Med. 8:692010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reiner A, Yekutieli D and Benjamini Y:
Identifying differentially expressed genes using false discovery
rate controlling procedures. Bioinformatics. 19:368–375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lopes CT, Franz M, Kazi F, Donaldson SL,
Morris Q and Bader GD: Cytoscape Web: An interactive web-based
network browser. Bioinformatics. 26:2347–2348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scardoni G, Petterlini M and Laudanna C:
Analyzing biological network parameters with CentiScaPe.
Bioinformatics. 25:2857–2859. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Felicetti F, Errico MC, Bottero L,
Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini
M, Colombo MP, et al: The promyelocytic leukemia zinc
finger-microRNA-221/-222 pathway controls melanoma progression
through multiple oncogenic mechanisms. Cancer Res. 68:2745–2754.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kappelmann M, Kuphal S, Meister G,
Vardimon L and Bosserhoff AK: MicroRNA miR-125b controls melanoma
progression by direct regulation of c-Jun protein expression.
Oncogene. 32:2984–2991. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H
and Hu C: Circulating microRNA-92a and microRNA-21 as novel
minimally invasive biomarkers for primary breast cancer. J Cancer
Res Clin Oncol. 139:223–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Creighton CJ, Hernandez-Herrera A,
Jacobsen A, Levine DA, Mankoo P, Schultz N, Du Y, Zhang Y, Larsson
E, Sheridan R, et al: Integrated analyses of microRNAs demonstrate
their widespread influence on gene expression in high-grade serous
ovarian carcinoma. PLoS One. 7:e345462012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim YK, Yu J, Han TS, Park SY, Namkoong B,
Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK and Kim VN: Functional links
between clustered microRNAs: Suppression of cell-cycle inhibitors
by microRNA clusters in gastric cancer. Nucleic Acids Res.
37:1672–1681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Parker BJ, Günter S and Bedo J:
Stratification bias in low signal microarray studies. BMC
Bioinformatics. 8:3262007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang CH, Yue J, Pfeffer SR, Handorf CR and
Pfeffer LM: MicroRNA miR-21 regulates the metastatic behavior of
B16 melanoma cells. J Biol Chem. 286:39172–39178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jukic DM, Rao UN, Kelly L, Skaf JS,
Drogowski LM, Kirkwood JM and Panelli MC: Microrna profiling
analysis of differences between the melanoma of young adults and
older adults. J Transl Med. 8:272010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Luan W, Qian Y, Ni X, Bu X, Xia Y, Wang J,
Ruan H, Ma S and Xu B: miR-204-5p acts as a tumor suppressor by
targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in
malignant melanoma. Onco Targets Ther. 10:1237–1246. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ding M, Lin B, Li T, Liu Y, Li Y, Zhou X,
Miao M, Gu J, Pan H, Yang F, et al: A dual yet opposite
growth-regulating function of miR-204 and its target XRN1 in
prostate adenocarcinoma cells and neuroendocrine-like prostate
cancer cells. Oncotarget. 6:7686–7700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Findlay VJ, Turner DP, Moussa O and Watson
DK: MicroRNA-mediated inhibition of prostate-derived Ets factor
messenger RNA translation affects prostate-derived Ets factor
regulatory networks in human breast cancer. Cancer Res.
68:8499–8506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Imam JS, Plyler JR, Bansal H, Prajapati S,
Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, et
al: Genomic loss of tumor suppressor miRNA-204 promotes cancer cell
migration and invasion by activating AKT/mTOR/Rac1 signaling and
actin reorganization. PLoS One. 7:e523972012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li W, Jin X, Zhang Q, Zhang G, Deng X and
Ma L: Decreased expression of miR-204 is associated with poor
prognosis in patients with breast cancer. Int J Clin Exp Pathol.
7:3287–3292. 2014.PubMed/NCBI
|
|
47
|
Turner DP, Findlay VJ, Moussa O,
Semenchenko VI, Watson PM, LaRue AC, Desouki MM, Fraig M and Watson
DK: Mechanisms and functional consequences of PDEF protein
expression loss during prostate cancer progression. Prostate.
71:1723–1735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Marfe G, De Martino L, Tafani M,
Irno-Consalvo M, Pasolini MP, Navas L, Papparella S, Gambacurta A
and Paciello O: A multicancer-like syndrome in a dog characterized
by p53 and cell cycle-checkpoint kinase 2 (CHK2) mutations and
sirtuin gene (SIRT1) down-regulation. Res Vet Sci. 93:240–245.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Firestein R, Blander G, Michan S,
Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S,
de Cabo R, Fuchs C, et al: The SIRT1 deacetylase suppresses
intestinal tumorigenesis and colon cancer growth. PLoS One.
3:e20202008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pećina-Slaus N, Zigmund M, Kusec V, Martić
TN, Cacić M and Slaus M: E-cadherin and beta-catenin expression
patterns in malignant melanoma assessed by image analysis. J Cutan
Pathol. 34:239–246. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rubinfeld B, Robbins P, El-Gamil M, Albert
I, Porfiri E and Polakis P: Stabilization of beta-catenin by
genetic defects in melanoma cell lines. Science. 275:1790–1792.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mueller DW, Rehli M and Bosserhoff AK:
miRNA expression profiling in melanocytes and melanoma cell lines
reveals miRNAs associated with formation and progression of
malignant melanoma. J Invest Dermatol. 129:1740–1751. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kuphal S, Palm HG, Poser I and Bosserhoff
AK: Snail-regulated genes in malignant melanoma. Melanoma Res.
15:305–313. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liao XH, Zheng L, He HP, Zheng DL, Wei ZQ,
Wang N, Dong J, Ma WJ and Zhang TC: STAT3 regulated ATR via
microRNA-383 to control DNA damage to affect apoptosis in A431
cells. Cell Signal. 27:2285–2295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rouse J and Jackson SP: Interfaces between
the detection, signaling, and repair of DNA damage. Science.
297:547–551. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen CF, Ruiz-Vega R, Vasudeva P, Espitia
F, Krasieva TB, de Feraudy S, Tromberg BJ, Huang S, Garner CP, Wu
J, et al: ATR mutations promote the growth of melanoma tumors by
modulating the immune microenvironment. Cell Rep. 18:2331–2342.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Satyanarayana A and Kaldis P: A dual role
of Cdk2 in DNA damage response. Cell Div. 4:92009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Grossman SR: p300/CBP/p53 interaction and
regulation of the p53 response. Eur J Biochem. 268:2773–2778. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ohashi E, Hong SH, Takahashi T, Nakagawa
T, Mochizuki M, Nishimura R and Sasak N: Effect of retinoids on
growth inhibition of two canine melanoma cell lines. J Vet Med Sci.
63:83–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Inoue K, Ohashi E, Kadosawa T, Hong SH,
Matsunaga S, Mochizuki M, Nishimura R and Sasaki N: Establishment
and characterization of four canine melanoma cell lines. J Vet Med
Sci. 66:1437–1440. 2004. View Article : Google Scholar : PubMed/NCBI
|
